Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 26, 2025 · Filed Nov 28, 2025
Adient's EMEA sold $49K of Adient shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$49,275
Shares × reported transaction price
21 days after results of Nov 5, 2025, 70 days before results of Feb 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.2% | +0.5% | −2.7% |
| 30 days | −0.1% | +0.2% | −0.3% |
| 90 days | +22.9% | +0.9% | +22.0% |
| 180 days | +18.4% | +11.5% | +6.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Not classified as an open-market trade.
Derivative exercise or conversion — not an open-market buy.